New developments in tetracycline antibiotics: glycylcyclines and tetracycline efflux pump inhibitors.
about
Functional, biophysical, and structural bases for antibacterial activity of tigecyclineStructural basis for TetM-mediated tetracycline resistancePutative dioxygen-binding sites and recognition of tigecycline and minocycline in the tetracycline-degrading monooxygenase TetXBacterial Multidrug Efflux Pumps: Much More Than Antibiotic Resistance DeterminantsEffects of Menthol Supplementation in Feedlot Cattle Diets on the Fecal Prevalence of Antimicrobial-Resistant Escherichia coliPharmacokinetics of Tigecycline after Single and Multiple Doses in Healthy SubjectsCoagulase-negative staphylococci.Tetracycline-tet repressor binding specificity: insights from experiments and simulations.Efficacy and safety of tigecycline monotherapy vs. imipenem/cilastatin in Chinese patients with complicated intra-abdominal infections: a randomized controlled trial.Effects of age and sex on single-dose pharmacokinetics of tigecycline in healthy subjects.The threat from the pink corner.Evaluation of a potential tigecycline-warfarin drug interaction.Modulation of Bacterial Multidrug Resistance Efflux Pumps of the Major Facilitator Superfamily.Cryo-EM structure of the tetracycline resistance protein TetM in complex with a translating ribosome at 3.9-Å resolution.Interaction of antibacterial compounds with RND efflux pumps in Pseudomonas aeruginosaEnterococcus faecalis resistant to linezolid: case series and review of the literature.Efflux-mediated antimicrobial resistance.Doxycycline impairs neutrophil migration to the airspaces of the lung in mice exposed to intratracheal lipopolysaccharide.Comparison of Antimicrobial Resistance in Escherichia coli Strains Isolated From Healthy Poultry and Swine Farm Workers Using Antibiotics in Korea.Prevalence of Antimicrobial Resistance in Escherichia coli Strains Isolated from Fishery Workers.Comparison of tigecycline and vancomycin for treatment of experimental foreign-body infection due to methicillin-resistant Staphylococcus aureusSynthesis and antibacterial activity of doxycycline neoglycosides.Understanding efflux in Gram-negative bacteria: opportunities for drug discovery.Inducement and reversal of tetracycline resistance in Escherichia coli K-12 and expression of proton gradient-dependent multidrug efflux pump genes.Effects of efflux transporter genes on susceptibility of Escherichia coli to tigecycline (GAR-936).AcrAB efflux pump plays a role in decreased susceptibility to tigecycline in Morganella morganii.The inhibition the Tet(K) efflux pump of tetracycline resistant Staphylococcus epidermidis by essential oils from three Salvia species.Update on Acinetobacter species: mechanisms of antimicrobial resistance and contemporary in vitro activity of minocycline and other treatment options.Occurrence of tetracycline resistance genes among Escherichia coli isolates from the phase 3 clinical trials for tigecycline.A Novel indole compound that inhibits Pseudomonas aeruginosa growth by targeting MreB is a substrate for MexAB-OprMPharmacokinetics and safety of a single intravenous dose of the antibiotic tigecycline in patients with cirrhosis.
P2860
Q24548264-40BF72B6-8567-4530-8F14-9832EB8287B6Q27673851-B8E9F0A3-0D23-4CAC-A756-5A9291953C1BQ27685449-E0620054-2FF5-4734-85E0-8509DC0CEB58Q28073636-14A244C8-0A33-45F6-B9F2-29BC2ACB6DA7Q28468520-7896D4EC-16D7-474D-A61F-20D5746258A6Q29398341-908F3210-4B23-4FD6-84B6-565B3E2DA4B8Q30401758-08F30FB1-18B3-450F-A9C0-4A7F78DE56E7Q30886899-75B6464E-7E2A-433F-A7EC-2364578C3E09Q33642184-B850388E-C41D-48B7-AC8B-49C1046A65F3Q33722140-BBF05DDE-C4BD-4CE2-A8F2-1E80C3DE8051Q34212044-35C135E8-D387-490E-8381-FE8709FA04CCQ34593514-6351771F-69B2-4080-BBD6-A37C4AE70F41Q35142025-D8CE3A01-851A-4E43-9C55-F36265D0FA64Q35567060-AD95418E-40DC-43A2-8425-839AAD577EEBQ35830489-2CF034A0-2CEA-4E25-94C4-C929B0EB6428Q35906331-598274D1-B81B-4F54-95BE-B78E9E981ED6Q36138147-1254EFAF-E3D6-4EE9-B47D-48E0F642E63CQ36298873-A035842C-51D6-43F1-AC83-1AD521346E85Q37083119-34E2852E-11B3-4771-AB1B-5D0B7049276BQ37156282-ADFEAA16-AA03-4E19-9DCA-7D85D9F83756Q37247619-60D5134B-B441-48D8-97EA-3B4BB63E31AEQ37270510-A4067389-9246-4D3A-9C21-85D0A200C656Q38011247-C3619811-C0C5-4084-8CAC-ACB6DF5E6089Q39563388-FA5312E4-99A6-48F3-9163-B755E467F468Q40882661-4499F010-977D-4634-8EBE-145E860737ABQ41005771-B7FCB9BF-52FE-4A44-B80D-C878B8A4F452Q41110833-542EF093-4D1F-413E-979A-CBA8BC93CDB7Q41676571-138F3F51-7FE1-46D7-8905-43CF75B8A103Q41909661-22615F17-8F80-4932-BDFD-3B5096C5FC6DQ42637266-D99B8AA0-190D-4E90-A279-1B9B9DEC7E29Q46555222-30406B66-5565-4A84-91C4-44F8DE3CA19A
P2860
New developments in tetracycline antibiotics: glycylcyclines and tetracycline efflux pump inhibitors.
description
2002 nî lūn-bûn
@nan
2002 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
New developments in tetracycli ...... ycline efflux pump inhibitors.
@ast
New developments in tetracycli ...... ycline efflux pump inhibitors.
@en
New developments in tetracycli ...... ycline efflux pump inhibitors.
@nl
type
label
New developments in tetracycli ...... ycline efflux pump inhibitors.
@ast
New developments in tetracycli ...... ycline efflux pump inhibitors.
@en
New developments in tetracycli ...... ycline efflux pump inhibitors.
@nl
prefLabel
New developments in tetracycli ...... ycline efflux pump inhibitors.
@ast
New developments in tetracycli ...... ycline efflux pump inhibitors.
@en
New developments in tetracycli ...... ycline efflux pump inhibitors.
@nl
P1476
New developments in tetracycli ...... ycline efflux pump inhibitors.
@en
P2093
Ian Chopra
P304
P356
10.1016/S1368-7646(02)00051-1
P577
2002-07-01T00:00:00Z